Universal- Beteiligungs- und Servicegesellschaft mbH
Position in LLY — ELI LILLY & Co
CIK 2057170
FRANKFURT AM MAIN, 2M
Position in LLY
as of Jun 30, 2026
· filed Aug 6, 2026
Position Value
$731,805,888
+$186,226,837 QoQ
Shares Held
610,128
+2.9% QoQ
Ownership
0.065%
of shares outstanding
% of Portfolio
1.14%
of 13F equity value
Holder Rank
#111
of 4,604 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 99%
Shared 1%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Universal- Beteiligungs- und Servicegesellschaft mbH holds $2,450,882,745 across 11 Drug Manufacturers - General names. LLY ranks #1 (29.9% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
610,128 | $731,805,888 | |
| 2 | JNJ |
Johnson & Johnson
|
2,206,076 | $560,277,121 | |
| 3 | ABBV |
AbbVie Inc.
|
1,448,017 | $364,378,997 | |
| 4 | MRK |
Merck & Co., Inc.
|
1,912,337 | $245,735,304 | |
| 5 | AMGN |
Amgen Inc
|
483,751 | $175,175,912 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
1,271,365 | $160,624,254 | |
| 7 | PFE |
Pfizer Inc
|
4,229,724 | $101,851,753 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
1,567,009 | $90,291,058 |
All Filings in LLY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $731,805,888 | 610,128 | Shares | Defined | 2026-08-06 | |
| 2026-03-31 | $545,579,051 | 593,169 | Shares | Defined | 2026-05-11 | |
| 2025-12-31 | $644,065,456 | 599,309 | Shares | Defined | 2026-01-28 | |
| 2025-09-30 | $482,987,393 | 633,011 | Shares | Defined | 2025-10-30 | |
| 2025-06-30 | $452,248,227 | 580,155 | Shares | Defined | 2025-08-11 | |
| 2025-03-31 | $434,662,392 | 526,283 | Shares | Defined | 2025-05-06 | |
| 2024-12-31 | $406,021,820 | 525,935 | Shares | Defined | 2025-02-28 | |
| No filing history on record for this holder in this stock. | ||||||